Medicines Optimisation
Hello [subscriber:firstname | default:reader].

COVID-19 - UK Pharmaceutical Industry Response

The Association of the British Pharmaceutical Industry have today launched a 'Responding to COVID-19' webpage, with information about the potential impact of the pandemic on the medicines supply chain and the steps being taken to safeguard supplies, including: The UK Government has asked pharmaceutical companies where possible to retain any remaining additional stockpiles of medicines that were built in preparation …

Read more

COVID-19 - NHSEI Prescription Advice

The NHS England and Improvement Medical Director for Primary Care, Dr Nikita Kanani, has issued a COVID-19 update to General Practices. The letter (available from the primary care page of the NHSE&I Coronavirus Guidance for Clinicians collection) includes the following important advice about prescriptions: Practices should not change their repeat prescription durations or support patients trying to stockpile: these actions …

Read more

Inhaler Prescribing - Carbon Footprint

The asthma inhaler patient decision aid published by NICE last year includes important information about the different carbon footprints of available devices - and highlights the fact that a typical metered dose aerosol inhaler (MDI) has a carbon footprint that is roughly TWENTY-FIVE times as big as that of a typical dry powder inhaler. The annual carbon footprint of primary care …

Read more

Nexplanon - New Insertion Site

The latest edition of Drug Safety Update from the MHRA reminds Healthcare Professionals that guidance on correct insertion of Nexplanon contraceptive implant has changed. The change is intended to minimise the risk of neurovascular injury and migration of the implant from the insertion site. The new insertion site is located in an area overlying the triceps muscle, a location generally …

Read more

Integrated Yellow Card Reporting - 93% GP coverage

The MHRA & EMIS have announced the roll-out of integrated reporting of suspected adverse drug reactions (ADRs) to the Yellow Card Scheme via EMIS Web, covering approximately 4000 GP practices. Reporting guidance for EMIS Web users can be found on EMIS Now. Integrated reporting is already in place with SystmOne and Vision. The development with EMIS Web means that integrated …

Read more

Medicines Support - HEE Training for Non-Registered Workforce

Health Education England have launched a set of training resources for the non-registered medicines workforce. To help people achieve essential skills, HEE have worked with health and social care colleagues and local Excellence Centres to develop a collection of medicines related training resources for non-registered staff across the wider workforce. These include: Medicines Administration e-Learning Modules for care workers in …

Read more

DHSC Medicine Supply and Shortage Updates - January 2020

The January 2020 edition of the Supply issues update for primary and secondary care from the Department of Health & Social Care is available - along with recent letters, memos & Medicine Supply Notifications - from the NHS Specialist Pharmacy Service (SPS)  . The January Supply issues update (also available from PrescQIPP) includes information on supplies of the following: Adcal …

Read more